PennaKem, a global leader in renewable chemistry and innovative products for a broad range of industries and since 2008 part of the Minafin Group based in Belgium, and OQEMA AG, a European market leader in the sales, marketing and distribution of speciality chemicals and food ingredients, have reinforced their sole distribution partnership for the distribution and sale of VIRIDISOL® M, a key solvent in the production of active ingredients for life science markets in France, Germany, Poland, the Czech Republic, Bulgaria, Hungary, Croatia, Slovenia, Romania and Slovakia.
Norbert Patouillard, director of sales in Europe and South America, comments, ‘We decided to continue our cooperation with OQEMA that is active in 21 European countries in order to further improve our market penetration. We used to be represented by Whyte Chemicals SARL, now OQEMA SAS in France, a member of the OQEMA Group. OQEMA SAS has extensive experience when it comes to products that will benefit the whole OQEMA Group sales force and allow us to maintain centralised coordination of the business, which is one of the keys to success for the industry.’
Dr James Berwick, European speciality Group director at OQEMA AG, comments, ‘As a leading distributor of speciality products across an expanding European geography of 21 countries, we are strategically expanding our intermediate portfolio to widen our offering to the significant production base of active ingredients across Europe. VIRIDISOL® M is a strong addition to our portfolio, complements our existing range, and, at the same time, strengthens our European position in the life science market.’
Norbert Patouillard, director of sales in Europe and South America, comments, ‘We decided to continue our cooperation with OQEMA that is active in 21 European countries in order to further improve our market penetration. We used to be represented by Whyte Chemicals SARL, now OQEMA SAS in France, a member of the OQEMA Group. OQEMA SAS has extensive experience when it comes to products that will benefit the whole OQEMA Group sales force and allow us to maintain centralised coordination of the business, which is one of the keys to success for the industry.’
Dr James Berwick, European speciality Group director at OQEMA AG, comments, ‘As a leading distributor of speciality products across an expanding European geography of 21 countries, we are strategically expanding our intermediate portfolio to widen our offering to the significant production base of active ingredients across Europe. VIRIDISOL® M is a strong addition to our portfolio, complements our existing range, and, at the same time, strengthens our European position in the life science market.’
